Nasdaq

Boston Scientific's (BSX) Wavewriter Alpha SCS Gets FDA's Nod

Boston Scientific, Inc. BSX recently received FDA approval for an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (“SCS”) Systems. With this approval, the system will be available ...
Healio

FDA approves expanded indication of spinal cord stimulation therapy

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an expanded indication of Boston Scientific’s spinal cord stimulation system that treats ...
Medical Device Network on MSN

Boston Scientific touts long-term data of SCS therapy

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Nasdaq

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...